313 Articles with the topic: Pharma & Medical Industry News
sea-maid submitted, created time 10 months 3 weeks (www.nature.com)
Bevacizumab, brand name Avastin, is the first anti-cancer drug designed specifically to starve tumors of blood. However, phase-three clinical trials seem to show that it is no more effective than chemotherapy alone.
There was a certain amount of industry drama associated with Avastin: Earlier this year Roche bought the company that produces it, Genentech, for $95 per share, a total of around $47 billion and a whole lot of nail-biting by Genentech employees, who value their company's freestyle corporate culture and feared that a takeover by Roche would stifle it 
Medarex signs licensing deal with Merck, MBL
piggy submitted, created time 10 months 3 weeks (www.reuters.com)
Medarex, MBL to get upfront payment of $60 million. Merck gains rights to develop, commercialize drugs.
Biotechnology company Medarex Inc signed a licensing agreement with Merck & Co Inc (MRK.N) and Massachusetts Biologic Laboratories, to develop a treatment for patients suffering from a hospital-acquired infection.
Under the terms, Merck gained worldwide rights to develop and commercialize CDA-1 and CDB-1, while Medarex and MBL will receive an upfront payment of $60 million and may receive payments of up to $165 million if certain milestones are achieved.
Sanofi to invest $90 mln in Lantus in China
piggy submitted, created time 10 months 3 weeks (news.bionews.com.cn)
Sanofi-Aventis, the world's fourth-biggest drug maker, will invest $90 million to boost output of the insulin Lantus in China, the company said in a statement on Tuesday.
The new investment follows a $94 million investment that Sanofi made in 2007 to build a manufacturing facility for products that prevent seasonal influenza.
Sanofi said that, taken together, the two investments make it the biggest investor in China's biological field.
In Denmark's Electronic Health Records Program, a Lesson for the U.S.
sea-maid submitted, created time 11 months 3 days (www.time.com)
The Frederiksberg University Hospital in Copenhagen looks like any other hospital in the developed world, except for one notable absence: there are no clipboards. Instead, doctors and nurses carry wireless handheld computers to call up the medical records of each patient, including their prescription history and drug allergies. If a doctor prescribes a medication that may cause complications, the computer's alarm goes off
Breakthrough model for human cancer may improve development of cancer drugs
piggy submitted, created time 11 months 1 week (www.eurekalert.org)
AVEO Pharmaceuticals, Inc., a biopharmaceutical company leveraging breakthrough discoveries in cancer biology to discover, develop and commercialize targeted oncology therapies, today announced findings from its novel human-in-mouse (HIM) cancer model system, in which AVEO successfully created invasive human tumors from primary human breast tissue. These tumors are placed in test mice, where they develop over time, mimicking the progress and responses of human tumors. The findings were published this week in the early edition of the Proceedings of the National Academy of Sciences.
Drug-eluting Stents Found Safe, Superior to Bare Metal Stents
sea-maid submitted, created time 11 months 2 weeks (www.sciencedaily.com)
Drug-eluting stents were found to be both safe and more effective than bare metal stents in preventing death and heart attacks among 262,700 real-world patients enrolled in a nationwide registry of cardiovascular disease, say researchers from Duke University Medical Center.
Pfizer ends trial early for cancer drug Sutent
piggy submitted, created time 11 months 2 weeks (finance.yahoo.com)
Pfizer Inc. said Thursday it stopped a late-stage study of the cancer drug Sutent to treat a form of advanced breast cancer but will continue examining the drug in several other mid- and late-stage trials.
The drug maker said it stopped a study that compared the results of Sutent with those of capecitabine when each was used alone in patients who had already tried standard treatments
US panel: Novo Nordisk tumor data concern for humans
piggy submitted, created time 11 months 2 weeks (www.reuters.com)
Novo Nordisk failed to provide data to show that thyroid tumors in rodents given its experimental diabetes drug would not pose a concern for people treated with the drug, a U.S. advisory panel said in a 12-1 vote on Thursday.
The committee of outside experts was set to vote later on whether the tumor findings should prevent marketing of the drug, liraglutide.
Potential new HIV drug may help patients not responding to other treatments
piggy submitted, created time 11 months 2 weeks (www.eurekalert.org)
This potential treatment for HIV may one day help people who are not responding to anti-retroviral therapy, suggests research due to be published tomorrow in the Journal of Immunology. Scientists looking at monkeys with the simian form of HIV were able to reduce the level of virus in the bloodstream to undetectable levels by adding a molecule called D-1mT to the monkeys' anti-retroviral therapy (ART).
Simian immunodeficiency virus (SIV) is very similar to the human immunodeficiency virus (HIV) and it is used to study the condition in animal models
Molecular farming becomes practical: One million doses of anti-HIV protein grown in plants
Darkfrog submitted, created time 11 months 2 weeks (www.nature.com)
1. It's a protein that interferes with HIV in human cell studies, probably by binding to the virus's surface. Unlike non-protein microbicides, it actually seems to work.
2. It was grown in plants. This means it would be cheap. Proteins of this kind are usually very expensive to mass-produce.
The genes coding for the protein were introduced into a type of tobacco plant called Nicotiana benthamiana using the tobacco mosaic virus. The protein itself is called griffithsin (GRFT), and is found in red algae
AIDS Drug Slows Spread of Deadly Childhood Brain Cancer
sea-maid submitted, created time 11 months 2 weeks (news.yahoo.com)
A drug approved to combat AIDS may also help slow the spread of a deadly type of brain tumor that tends to attack children.
Transforming medical diagnosis with new scanning technology
piggy submitted, created time 11 months 2 weeks (www.eurekalert.org)
Scientists at the University of York have developed a new technology that dramatically improves the sensitivity of magnetic resonance techniques, including those used in hospital scanners and chemistry laboratories.
Ultimately, this technique, based on manipulating parahydrogen, best known as the fuel used on space shuttles, is expected to lower costs while increasing the range of medical conditions that can be examined.
The research is published in the latest edition of the journal Science.
Roche controls 96.2 percent of Genentech as bid closes
piggy submitted, created time 11 months 3 weeks (www.reuters.com)
Swiss drugmaker Roche Holding AG said on Thursday it controlled a total of 96.2 percent of Genentech shares after completing its tender offer for the 44 percent stake it did not already own.
Roche said remaining holders of Genentech shares would revive $95 a share. Genentech will cease to be traded on the New York Stock Exchange, Roche said.
After a drawn-out battle, the Swiss drugmaker finally clinched a deal earlier this year for part of the U.S. biotech group it did not own for $46.8 billion.
FDA Approves New Indication for Wyeth's TYGACIL (tigecycline)
piggy submitted, created time 11 months 3 weeks (www.bizjournals.com)
Wyeth Pharmaceuticals, a division of Wyeth announced today that the U.S. Food and Drug Administration (FDA) approved TYGACIL(R) (tigecycline), for the treatment of adult patients with community-acquired bacterial pneumonia (CABP) caused by susceptible strains of indicated pathogens. TYGACIL was first approved by the FDA in 2005 for the treatment of complicated intra-abdominal infections (cIAI) and complicated skin and skin structure infections (cSSSI) caused by susceptible strains of indicated pathogens in adults.
First Automated Carbohydrate Assembly Line Opens Door to New Field of Medicine
piggy submitted, created time 11 months 3 weeks (www.sciencedaily.com)
Scientists from Germany have reported a major advance toward opening the doors of a carbohydrate-based medicine chest for the 21st century. Much more than just potatoes and pasta, these carbohydrates may form the basis of revolutionary new vaccines and drugs to battle malaria, HIV, and a bevy of other diseases.
Speaking at the 237th National Meeting of the American Chemical Society, Peter H. Seeberger, Ph.D
abuse@discover8.com
kavin
angelfish
jane2007
Sue Wu
DanyC
GenScript's custom antibody service guarantees final product with an ELISA titer of 1:20,000 or two ELISA positive clones with advanced FREE antigen design tool.
www.genscript.com
Gene Synthesis
GenScript's custom gene synthesis service starts as LOW as $0.39/bp, with advanced FREE codon optimization tool and seamless cloning technology.
www.genscript.com